1-3 of 3
Joel M. Reid
Close
Sort by
Journal Articles

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Wilson I. Gonsalves, Natalia Neparidze, Jacob B. Allred, Shaji K Kumar, Joel M. Reid, Geoffrey Shapiro, Brian A. Costello, Richard Piekarz, Rachid C. Baz, Srinivas Devarakonda
Journal: Blood
Blood (2022) 140 (Supplement 1): 7315–7316.
https://doi.org/10.1182/blood-2022-164966
Published: 2022
Journal Articles

A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A -Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1

Erin Guest, John Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J. Carroll, Nyla A. Heerema, Holly Kubaney, Amanda August, Melinda Pauly, Daniel Wechsler, Rodney R. Miles, Joel M. Reid, Cynthia Kihei, Lia Gore, Elizabeth A. Raetz, Stephen P. Hunger, Mignon L. Loh, Patrick A. Brown
Journal: Blood
Blood (2022) 140 (Supplement 1): 3256–3257.
https://doi.org/10.1182/blood-2022-167765
Published: 2022
Journal Articles

Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2

Elizabeth A. Raetz, MD, Mitchell S. Cairo, MD, Michael J. Borowitz, MD, PhD, Xiaomin Lu, PhD, Meenakshi Devidas, PhD, Joel M. Reid, PhD, David M. Goldenberg, ScD, MD, William A Wegener, MD, PhD, James A. Whitlock, MD, Peter C. Adamson, MD, Stephen P Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2011) 118 (21): 573.
https://doi.org/10.1182/blood.V118.21.573.573
Published: 2011